Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes

NCT03159052 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: SHR3824
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.